{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:14:18Z","timestamp":1769606058566,"version":"3.49.0"},"reference-count":32,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2018,1,27]]},"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Amyloidosis is caused by deposition of abnormal protein fibrils, leading to damage of organ function. Hereditary amyloidosis represents a monogenic disease caused by germline mutations in 11 amyloidogenic precursor protein genes. One of the important but non-specific symptoms of amyloidosis is hypertrophic cardiomyopathy. Diagnostics of hereditary amyloidosis is complicated and the real cause can remain overlooked. We aimed to design hereditary amyloidosis gene panel and to introduce new next-generation sequencing (NGS) approach to investigate hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Design of target enrichment DNA library preparation using Haloplex Custom Kit containing 11 amyloidogenic genes was followed by MiSeq Illumina sequencing and bioinformatics identification of germline variants using tool VarScan in a cohort of 40 patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We present design of NGS panel for 11 genes (<jats:italic>TTR<\/jats:italic>, <jats:italic>FGA<\/jats:italic>, <jats:italic>APOA1<\/jats:italic>, <jats:italic>APOA2<\/jats:italic>, <jats:italic>LYZ<\/jats:italic>, <jats:italic>GSN<\/jats:italic>, <jats:italic>CST3<\/jats:italic>, <jats:italic>PRNP<\/jats:italic>, <jats:italic>APP<\/jats:italic>, <jats:italic>B2M<\/jats:italic>, <jats:italic>ITM2B<\/jats:italic>) connected to various forms of amyloidosis. We detected one mutation, which is responsible for hereditary amyloidosis. Some other single nucleotide variants are so far undescribed or rare variants or represent common polymorphisms in European population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We report one positive case of hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance and set up first panel for NGS in hereditary amyloidosis. This work may facilitate successful implementation of the NGS method by other researchers or clinicians and may improve the diagnostic process after validation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jclinpath-2017-204978","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T12:15:20Z","timestamp":1518869720000},"page":"687-694","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing"],"prefix":"10.1136","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-2532","authenticated-orcid":false,"given":"Zuzana","family":"Chyra Kufova","sequence":"first","affiliation":[{"name":"Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic"},{"name":"Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic"},{"name":"Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tereza","family":"Sevcikova","sequence":"additional","affiliation":[{"name":"Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic"},{"name":"Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Januska","sequence":"additional","affiliation":[{"name":"Cardiocentre Podlesi, Trinec, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Vojta","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpad","family":"Boday","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Department of Medical Genetics, Laboratory AGEL, Novy Jicin, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavla","family":"Vanickova","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Department of Medical Genetics, Laboratory AGEL, Novy Jicin, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Filipova","sequence":"additional","affiliation":[{"name":"Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic"},{"name":"Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic"},{"name":"Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Growkova","sequence":"additional","affiliation":[{"name":"Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic"},{"name":"Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic"},{"name":"Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Jelinek","sequence":"additional","affiliation":[{"name":"Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic"},{"name":"Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic"},{"name":"Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Hajduch","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Hajek","sequence":"additional","affiliation":[{"name":"Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic"},{"name":"Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"2025092502125033000_71.8.687.1","first-page":"1166.e1","article-title":"Wild-type transthyretin cardiac amyloidosis: novel insights from advanced imaging","volume":"32","author":"Narotsky","year":"2016","journal-title":"Can J Cardiol"},{"key":"2025092502125033000_71.8.687.2","first-page":"770","article-title":"Systemic amyloidosis: novel therapies and role of biomarkers","volume":"32","author":"Nuvolone","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2025092502125033000_71.8.687.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.171"},{"key":"2025092502125033000_71.8.687.4","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2016.1257986"},{"key":"2025092502125033000_71.8.687.5","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2010.526812"},{"key":"2025092502125033000_71.8.687.6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20644"},{"key":"2025092502125033000_71.8.687.7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-31"},{"issue":"Suppl 1","key":"2025092502125033000_71.8.687.8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","article-title":"Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP","volume":"29","author":"Parman","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"2025092502125033000_71.8.687.9","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/j.crvasa.2012.11.018","article-title":"Cardiac amyloidosis: A comprehensive review","volume":"55","author":"Fikrle","year":"2013","journal-title":"Cor Vasa"},{"key":"2025092502125033000_71.8.687.10","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22619"},{"key":"2025092502125033000_71.8.687.11","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu170"},{"key":"2025092502125033000_71.8.687.12","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu356"},{"key":"2025092502125033000_71.8.687.13","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110"},{"key":"2025092502125033000_71.8.687.14","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"2025092502125033000_71.8.687.15","doi-asserted-by":"publisher","DOI":"10.1101\/gr.129684.111"},{"key":"2025092502125033000_71.8.687.16","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22932"},{"key":"2025092502125033000_71.8.687.17","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2890"},{"key":"2025092502125033000_71.8.687.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046688","article-title":"Predicting the functional effect of amino acid substitutions and indels","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"key":"2025092502125033000_71.8.687.19","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1754"},{"key":"2025092502125033000_71.8.687.20","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbs017"},{"key":"2025092502125033000_71.8.687.21","doi-asserted-by":"publisher","DOI":"10.1038\/nature15393"},{"key":"2025092502125033000_71.8.687.22","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00415-012-6529-z","article-title":"Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary amyloidosis","volume":"259","author":"Briani","year":"2012","journal-title":"J Neurol"},{"key":"2025092502125033000_71.8.687.23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws102"},{"key":"2025092502125033000_71.8.687.24","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-015-9480-0"},{"key":"2025092502125033000_71.8.687.25","doi-asserted-by":"publisher","DOI":"10.1038\/nature12402"},{"key":"2025092502125033000_71.8.687.26","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320600104"},{"key":"2025092502125033000_71.8.687.27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1873-3468.12093","article-title":"Amyloid properties of the leader peptide of variant B cystatin C: implications for alzheimer and macular degeneration","volume":"590","author":"Sant\u2019Anna","year":"2016","journal-title":"FEBS Lett"},{"key":"2025092502125033000_71.8.687.28","doi-asserted-by":"crossref","unstructured":"Ikejiri M , Wada H , Kamimoto Y , et al . Protection from pregnancy loss in women with hereditary thrombophilia when associated with fibrinogen polymorphism Thr331Ala. Clin Appl Thromb Hemost 2017;23.doi:10.1177\/1076029616645400","DOI":"10.1177\/1076029616645400"},{"key":"2025092502125033000_71.8.687.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-005-0102-0"},{"key":"2025092502125033000_71.8.687.30","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-10-122","article-title":"Prediction of disease-related mutations affecting protein localization","volume":"10","author":"Laurila","year":"2009","journal-title":"BMC Genomics"},{"key":"2025092502125033000_71.8.687.31","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20887"},{"issue":"Suppl 1","key":"2025092502125033000_71.8.687.32","first-page":"134","article-title":"Abstract 19305: higher levels of beta-2 microglobulin predict incident hypertension","volume":"134","author":"Shih-Jen Hwang","year":"2016","journal-title":"Circulation"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2017-204978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:13:09Z","timestamp":1758791589000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2017-204978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,7,18]]},"published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1136\/jclinpath-2017-204978"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2017-204978","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]}}}